Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations

被引:29
作者
Lamb, ML [1 ]
Jorgensen, WL [1 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
关键词
D O I
10.1021/jm980062o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The binding and solution-phase properties of six inhibitors of FK506 binding protein (FKBP12) were investigated using free energy perturbation techniques in Monte Carlo statistical mechanics simulations. These nonimmunosuppressive molecules are of current interest for their neurotrophic activity when bound to FKBP12 as well as for their potential as building blocks for chemical inducers of protein dimerization. Relative binding affinities were computed and analyzed for ligands differing by a phenyl ring, an external phenyl or pyridyl substituent, and a pipecolyl or prolyl ring. Such results are, in general, valuable for inhibitor optimization and, in the present case, bring into question some of the previously reported binding data.
引用
收藏
页码:3928 / 3939
页数:12
相关论文
共 60 条
[21]   PEPTIDYL-PROLYL CIS/TRANS ISOMERASES AND THEIR EFFECTORS [J].
FISCHER, G .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1994, 33 (14) :1415-1436
[22]   A MECHANISM FOR ROTAMASE CATALYSIS BY THE FK506 BINDING-PROTEIN (FKBP) [J].
FISCHER, S ;
MICHNICK, S ;
KARPLUS, M .
BIOCHEMISTRY, 1993, 32 (50) :13830-13837
[23]   A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration [J].
Gold, BG ;
ZelenyPooley, M ;
Wang, MS ;
Chaturvedi, P ;
Armistead, DM .
EXPERIMENTAL NEUROLOGY, 1997, 147 (02) :269-278
[24]   X-RAY STRUCTURE OF CALCINEURIN INHIBITED BY THE IMMUNOPHILIN IMMUNOSUPPRESSANT FKBP12-FK506 COMPLEX [J].
GRIFFITH, JP ;
KIM, JL ;
KIM, EE ;
SINTCHAK, MD ;
THOMSON, JA ;
FITZGIBBON, MJ ;
FLEMING, MA ;
CARON, PR ;
HSIAO, K ;
NAVIA, MA .
CELL, 1995, 82 (03) :507-522
[25]  
HAMILTON G, 1997, Patent No. 5614547
[26]   FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of Parkinson's disease [J].
Hamilton, GS ;
Huang, W ;
Connolly, MA ;
Ross, DT ;
Guo, H ;
Valentine, HL ;
Suzdak, PD ;
Steiner, JP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) :1785-1790
[27]  
Hamilton GS, 1997, CURR PHARM DESIGN, V3, P405
[28]   Dimeric ligands define a role for transcriptional activation domains in reinitiation [J].
Ho, SN ;
Biggar, SR ;
Spencer, DM ;
Schreiber, SL ;
Crabtree, GR .
NATURE, 1996, 382 (6594) :822-826
[29]   STRUCTURE-ACTIVITY STUDIES OF SYNTHETIC FKBP LIGANDS AS PEPTIDYL-PROLYL ISOMERASE INHIBITORS [J].
HOLT, DA ;
KONIALIANBECK, AL ;
OH, HJ ;
YEN, HK ;
ROZAMUS, LW ;
KROG, AJ ;
ERHARD, KF ;
ORTIZ, E ;
LEVY, MA ;
BRANDT, M ;
BOSSARD, MJ ;
LUENGO, JI .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (02) :315-320
[30]   DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12 [J].
HOLT, DA ;
LUENGO, JI ;
YAMASHITA, DS ;
OH, HJ ;
KONIALIAN, AL ;
YEN, HK ;
ROZAMUS, LW ;
BRANDT, M ;
BOSSARD, MJ ;
LEVY, MA ;
EGGLESTON, DS ;
LIANG, J ;
SCHULTZ, LW ;
STOUT, TJ ;
CLARDY, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (22) :9925-9938